Clinical Drug Experience Knowledgebase

Adenocarcinoma (Phase 3)

Adenocarcinoma of Lung (Phase 3)

Biliary Tract Neoplasms (Phase 2)

Breast Neoplasms (Phase 3)

Carcinoma (Phase 2)

Carcinoma, Hepatocellular (Phase 2)

Carcinoma, Ovarian Epithelial (Phase 1)

Chondrosarcoma (Phase 2)

Chondrosarcoma, Clear Cell (Phase 2)

Chondrosarcoma, Mesenchymal (Phase 2)

Colonic Neoplasms (Phase 1)

Colorectal Neoplasms (Phase 2)

Fibromatosis, Aggressive (Phase 2)

Gastrointestinal Stromal Tumors (Phase 2)

Hodgkin Disease (Phase 3)

Inflammatory Breast Neoplasms (Phase 3)

Leukemia (Phase 2)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 3)

Leukemia, Myeloid (Phase 3)

Leukemia, Myeloid, Chronic-Phase (Phase 3)

Liposarcoma (Phase 2)

Lymphoma (Phase 3)

Lymphoma, B-Cell (Phase 2)

Lymphoma, Large B-Cell, Diffuse (Phase 2)

Lymphoma, Non-Hodgkin (Phase 3)

Lymphoma, T-Cell (Phase 3)

Meningeal Carcinomatosis (Phase 2)

Meningitis (Phase 2)

Neoplasm Metastasis (Phase 2)

Neoplasms (Phase 2)

Neoplastic Cells, Circulating (Phase 2)

Neuroendocrine Tumors (Phase 2)

Osteosarcoma (Phase 2)

Ovarian Neoplasms (Phase 1)

Pain, Postoperative (Phase 3)

Pancreatic Neoplasms (Phase 2)

Peritoneal Neoplasms (Phase 2)

Prostatic Neoplasms (Phase 3)

Recurrence (Phase 2)

Sarcoma (Phase 3)

Sarcoma, Ewing (Phase 2)

Stomach Neoplasms (Phase 2)

Thyroid Neoplasms (Phase 2)

Triple Negative Breast Neoplasms (Phase 2)

Urinary Bladder Neoplasms (Phase 2)